Asarina Pharma AB (publ)

OM:ASAP Stock Report

Market Cap: SEK 634.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Asarina Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Peter Nordkild

Chief executive officer

SEK 2.7m

Total compensation

CEO salary percentage73.2%
CEO tenure8.8yrs
CEO ownership1.2%
Management average tenureno data
Board average tenure6.8yrs

Recent management updates

Recent updates

Companies Like Asarina Pharma (STO:ASAP) Could Be Quite Risky

Jun 09
Companies Like Asarina Pharma (STO:ASAP) Could Be Quite Risky

CEO Compensation Analysis

How has Peter Nordkild's remuneration changed compared to Asarina Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023SEK 3mSEK 2m

-SEK 13m

Sep 30 2023n/an/a

-SEK 14m

Jun 30 2023n/an/a

-SEK 15m

Mar 31 2023n/an/a

-SEK 14m

Dec 31 2022SEK 2mSEK 2m

-SEK 13m

Sep 30 2022n/an/a

-SEK 12m

Jun 30 2022n/an/a

-SEK 17m

Mar 31 2022n/an/a

-SEK 29m

Dec 31 2021SEK 3mSEK 2m

-SEK 32m

Sep 30 2021n/an/a

-SEK 49m

Jun 30 2021n/an/a

-SEK 59m

Mar 31 2021n/an/a

-SEK 63m

Dec 31 2020SEK 3mSEK 3m

-SEK 75m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 75m

Mar 31 2020n/an/a

-SEK 80m

Dec 31 2019SEK 3mSEK 3m

-SEK 71m

Sep 30 2019n/an/a

-SEK 69m

Jun 30 2019n/an/a

-SEK 65m

Mar 31 2019n/an/a

-SEK 48m

Dec 31 2018SEK 3mSEK 3m

-SEK 44m

Compensation vs Market: Peter's total compensation ($USD262.15K) is about average for companies of similar size in the Swedish market ($USD253.61K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.

CEO

Peter Nordkild (69 yo)

8.8yrs

Tenure

SEK 2,690,000

Compensation

Mr. Peter Nordkild, M.D. is Chief Executive Officer of Adenium Biotech ApS. Mr. Nordkild serves as Chief Executive Officer of ARTS Biologics. He is Chief Medical Officer at Asarina Pharma AB (publ) (former...

Board Members

NamePositionTenureCompensationOwnership
Torbjörn Bäckström
Chairman of Scientific Advisory Boardno datano data1.61%
SEK 10.2k
Paul de Potocki
Independent Chairman6.8yrsSEK 510.00kno data
Erin Gainer
Independent Director4.8yrsSEK 205.00kno data
Marianne Kock
Independent Director6.8yrsSEK 205.00kno data
Marie Bixo
Member of Scientific Advisory Boardno datano datano data
Marco Bortolato
Member of Scientific Advisory Boardno datano datano data
C. Epperson
Member of Scientific Advisory Boardno datano datano data

6.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: ASAP's board of directors are considered experienced (6.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/03 14:03
End of Day Share Price 2024/10/01 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Asarina Pharma AB (publ) is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ole-Andreas KrohnDNB Markets
Patrik LingDNB Markets
Anders HedlundRedeye